Search Results for 'Brca Breast'

Brca Breast published presentations and documents on DocSlides.

56 th
56 th
by liane-varnes
Annual Ob-Gyn Update. Ovarian Cancer:. Finally. ...
Case Discussion: Second
Case Discussion: Second
by celsa-spraggs
Opinion. 55 year-old woman with . recurrent . ova...
 Patient Selection for PARP
Patient Selection for PARP
by sherrill-nordquist
Inhibitors:. Purpose and Practicalities . Present...
Please note, these are the actual video-recorded
Please note, these are the actual video-recorded
by blindnessinfluenced
proceedings from the live CME event and may includ...
TheXevaUsersGuideArvindMer12andBenjaminHaibeKains123451Princess
TheXevaUsersGuideArvindMer12andBenjaminHaibeKains123451Princess
by isla
TheXevaUser'sGuide1Introduction TheXevapackageprov...
PackageXevaJune152021TypePackageTitleAnalysisofpatientderivedxenog
PackageXevaJune152021TypePackageTitleAnalysisofpatientderivedxenog
by delcy
2ABCAUC..............................................
ACC ACC BLCA BLCA BRCA BRCA
ACC ACC BLCA BLCA BRCA BRCA
by hadly
CESC. CESC. CHOL. CHOL. COAD. COAD. DLCB. DLCB. ES...
Why and how to test for germline
Why and how to test for germline
by isabella2
BRCA. mutations in Pancreatic Cancer. ESDO Learni...
Supplementary data Identication of novel intronic BRCA
Supplementary data Identication of novel intronic BRCA
by tatyana-admore
Genet 90 327331 Table 1 Oligodeoxyribonucleotide...
Growth Patterns and Pathobiology of Experimental and
Growth Patterns and Pathobiology of Experimental and
by pamella-moone
Clinical Malignancies. In Vivo. Updated: March . ...
State of the Art in  BRCA
State of the Art in BRCA
by ellena-manuel
-Mutated Ovarian Cancer. This program will includ...
PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update
PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update
by ellena-manuel
Program Overview . Discussion Outline. DNA Repair...
Preventive Screenings at no cost to you
Preventive Screenings at no cost to you
by jane-oiler
Covered at 100% in-network, not subject to deduct...
The Nurse View: Clinical Considerations in the Management of
The Nurse View: Clinical Considerations in the Management of
by natalia-silvester
BRCA. -Mutated Advanced Ovarian Cancer. Moderator...
by medshair
Five-year . survival. 15%. 30%. 40%. ?50%?. First ...
Ovarian Cancer: Standards of Care and New Opportunities
Ovarian Cancer: Standards of Care and New Opportunities
by majerepr
Robert L. Coleman, M.D.. Professor & . Vice Ch...
Genetic testing in ovarian cancer
Genetic testing in ovarian cancer
by BlueEyedBeauty
Dr Katie Snape. Joint Lead Consultant for Cancer G...
Looking ahead: Genomic Laboratory Hub
Looking ahead: Genomic Laboratory Hub
by LaughsALot
Rachel Butler, Head of Bristol Genetics Laboratory...